8EM trade ideas
Long-term Moon Shot | Editas MedicineEditas Medicine is a clinical stage genome editing company,
With the help of CRISPR technology, it focuses on treating a range of serious diseases like:
-Leber Congenital Amaurosis type 10 (Genetic form of vision loss that leads to blindness in childhood) - EDIT-101 has recently entered phase 1/2 trial for the treatment, the very first time an in vivo CRISPR treatment enters clinical trials which with positive results could instantly make Editas a leader in this new field!
-Usher Syndrome 2A (Form of retinitis pigmentosa that also includes hearing loss)
-Treats sickle cell diseases and beta-thalassemia (A blood disorder that reduces the production of hemoglobin)
It is also
-In collaboration with Juno Therapeutics to develop engineered T cells for cancer!
-Agreement with Allergan Pharmaceuticals International Limited to innovate, discover and develop new gene editing medicines for a range of ocular disorder
-Collaboration with Asklepios BioPharmaceutical to develop therapy to treat neurological diseases
The company has a lot of potential ahead in upcoming years!
Let's get more technical!
UNDERVALUED, I believe now would be a good time to lock in a long term position due to those facts
-Recently had a public offering of 3.5M at $66 per share (Jan 21st)
-Pe Ratio -39x
-Fair Value of $479.88 US
-Fib Retracement to current lows indicates a potential entry for the long term
-LONG TERM TIMEFRAME 1D LOOKS PROMISING AS WELL!
$EDITNice bounce off resistance and fib, broke out of falling wedge. Buying any pull backs so long as we close above black line stop loss would be a little below last candle breakdown.
EDITClearly a lot of value has been lost in the past month. The CSO stepped down and analysts downgraded projected revenue. EDIT has very lucrative candidates in the pipeline treating sickle cell anemia. Long-term, this company will most certainly be profitable, with significant patent protection. This is a short term down draft that is consolidating, for the near term, around a non-speculation, fair price of $63.
$EDITEntry price : 83.81
Fundamentals :
- Sector: Medical - Biotech
- EPS % Chg (Last Qtr): 130%
- EPS % Chg (Previous Qtr): 38%
- 3 Year EPS Growth Rate: 0%
- EPS Est % Chg (Current Yr): 0%
- Sales % Chg (Last Qtr): 1532%
- Sales % Chg (Previous Qtr): 361%
- 3-Year Sales Growth Rate: 44%
- Annual Pre -Tax Margin: -651.4%
LONG - Ready for it's Next Leg Up.Im bullish with EDIT here - Price is sitting on support and FIB 50% retracement level.
Looks like EDIT is ready for it's next move up.
Double bottom breakoutArk has bought up a lot of this along with crspr.
Held that 61$ support line and bounce off with nice volume.
Double bottom conformation line (Yellow)
entry 67$
Targets are green lines
EDIT 3 day CMF crossing down 0 line
For the first time since the parabolic move CMF goes down 0 line which signals a potential down trend in the making. Be a little more cautious in the near term.
Disclaimer, this is only for entertainment and education purposes and doesn't serve by any means as a buy or sell recommendation.
Personally I hold both long term long positions and occasionally short term short position, for disclosure purpose.
EDIT 3 day chart bullish signalI started covering CRSP/NTLA/EDIT way back last year in August while they haven't caught people's attention staying under the radar. Now they have made significant move but the move will continue it seems.
EDIT 3 day chart shows hidden divergence of StocRSI while price staying above key MAs.
On the near term EDIT might see some selling pressure it looks like with the day chart bearish Pin bar. watch out for some good buying opportunities.
Holding positions.
Disclaimer, this is only for entertainment and education purposes and doesn't serve by any means as a buy or sell recommendation.
Personally I hold both long term long positions and occasionally short term short position, for disclosure purpose.
$EDIT - entry at $80Entry at $80 with volume and then again @ $83.
Riding to $100 is the goal
Wait for the trade to come to you.
$EDIT - which way will it go? This is one of my favorite genome stocks.
$CRSP is my other favorite.
It has a pattern showing it could go either way.
ARK likes it, I like it, i've made a lot of money in options and now i hold commons
If it dips to $70, its a no brainer buy for me. Holding to $100
Crispr is here to stayLooks like a lot studies are reporting positive news, I think there is going to rally within crispr stocks.
Fibonacci sequence currently in HIGH ALERT. 🥵 My technical analysis represents my thoughts and opinions and should not be used as trading advice or investment planning; as we see today we had an explosive move towards the upside now after tracing off The Fibonacci sequence starting from the low of the day towards the high we can see various levels of support one being $80 0.5 in the sequence of Fibonacci. If prices hold at this level or levels $78-$79 looks up by contract calls for this week at the strike of $90. Look for a move towards the upside for 10% with volatility and then offload calls and reposition if needed. I hope my insight can be helpful and I hope y’all can make some money!
High Tight Flag on a power play opportunityNASDAQ:EDIT Big time power play on the high tight flag. Volume is coming right down as the trading range is getting really tight. I will be looking for a buy through Dec 17th high to break
the descending resistance with a tight stop on the hourly intra day or lod.
$EDIT at risk Must hold the uptrend or its at risk of breaking down to possibly fill the gap?
Will be watching this closely. If it maintains the trend line, it could be gearing up for a another rally.
